Treatment of obesity

Circulation Research

Volumn 118, Issue 11, 2016, Pages 1844-1855

  Wolfe, Bruce M ^a   Kvach, Elizaveta ^a   Eckel, Robert H ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

cardiac metabolism; hypertension; inflammation; obesity; sleep apnea

Indexed keywords

ADVERSE EFFECTS; BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; COMPLICATION; HUMAN; OBESITY; PROCEDURES; WEIGHT REDUCTION;

BARIATRIC SURGERY; CARDIOVASCULAR DISEASES; HUMANS; OBESITY; WEIGHT LOSS;

EID: 84971250018     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.116.307591     Document Type: Review

References (120)

1. Kuczmarski RJ, Flegal KM, Criteria for definition of overweight in transition: background and recommendations for the United States. Am J Clin Nutr 2000 72 1074 1081
2. Ludwig DS, Ebbeling CB, Weight-loss maintenance-mind over matter? N Engl J Med 2010 363 2159 2161. doi: 10.1056/NEJMe1011361
3. Sutherland JP, McKinley B, Eckel RH, The metabolic syndrome and inflammation. Metab Syndr Relat Disord 2004 2 82 104. doi: 10.1089/met.2004.2.82
4. Rejeski WJ, Bray GA, Chen SH, Clark JM, Evans M, Hill JO, Jakicic JM, Johnson KC, Neiberg R, Ip EH, Look AHEAD Research Group Aging and physical function in type 2 diabetes: 8 years of an intensive lifestyle intervention. J Gerontol A Biol Sci Med Sci 2015 70 345 353. doi: 10.1093/gerona/glu083
5. Yanovski SZ, Yanovski JA, Long-Term drug treatment for obesity: A systematic and clinical review. JAMA 2014 311 74 86. doi: 10.1001/jama.2013.281361
6. Frühbeck G, Bariatric and metabolic surgery: A shift in eligibility and success criteria. Nat Rev Endocrinol 2015 11 465 477. doi: 10.1038/nrendo.2015.84
7. Müller-Stich BP, Senft JD, Warschkow R, Kenngott HG, Billeter AT, Vit G, Helfert S, Diener MK, Fischer L, Büchler MW, Nawroth PP, Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: A systematic review and meta-Analysis. Ann Surg 2015 261 421 429. doi: 10.1097/SLA.0000000000001014
8. Vetter ML, Vinnard CL, Wadden TA, Perioperative safety and bariatric surgery. N Engl J Med 2009 361. author reply 1911. doi: 10.1056/NEJMc091728
9. Herpertz S, Kielmann R, Wolf AM, Hebebrand J, Senf W, Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res 2004 12 1554 1569. doi: 10.1038/oby.2004.195
10. Mitchell JE, Selzer F, Kalarchian MA, Devlin MJ, Strain GW, Elder KA, Marcus MD, Wonderlich S, Christian NJ, Yanovski SZ, Psychopathology before surgery in the longitudinal assessment of bariatric surgery-3 (LABS-3) psychosocial study. Surg Obes Relat Dis 2012 8 533 541. doi: 10.1016/j.soard.2012.07.001
11. Jones-Corneille LR, Wadden TA, Sarwer DB, Faulconbridge LF, Fabricatore AN, Stack RM, Cottrell FA, Pulcini ME, Webb VL, Williams NN, Axis I psychopathology in bariatric surgery candidates with and without binge eating disorder: results of structured clinical interviews. Obes Surg 2012 22 389 397. doi: 10.1007/s11695-010-0322-9
12. Mason EE, Ito C, Gastric bypass in obesity. Surg Clin North Am 1967 47 1345 1351
13. Shikora SA, Wolfe BM, Apovian CM, Anvari M, Sarwer DB, Gibbons RD, Ikramuddin S, Miller CJ, Knudson MB, Tweden KS, Sarr MG, Billington CJ, Sustained weight loss with vagal nerve blockade but not with sham: 18-month results of the recharge trial. J Obes 2015 2015 365604. doi: 10.1155/2015/365604
14. ReShape and Orbera-Two gastric balloon devices for weight loss. Med Lett Drugs Ther 2015 57 122 123
15. Flum DR, Dellinger EP, Impact of gastric bypass operation on survival: A population-based analysis. J Am Coll Surg 2004 199 543 551. doi: 10.1016/j.jamcollsurg.2004.06.014
16. Hatfield MD, Ashton CM, Bass BL, Shirkey BA, Surgeon-Specific Reports in General Surgery: Establishing Benchmarks for Peer Comparison Within a Single Hospital. J Am Coll Surg 2016 222 113 121. doi: 10.1016/j.jamcollsurg.2015.10.017
17. Benotti P, Wood GC, Winegar DA, Petrick AT, Still CD, Argyropoulos G, Gerhard GS, Risk factors associated with mortality after Roux-en-Y gastric bypass surgery. Ann Surg 2014 259 123 130. doi: 10.1097/SLA.0b013e31828a0ee4
18. Belle SH, Berk PD, Chapman WH, LABS Consortium Baseline characteristics of participants in the Longitudinal Assessment of Bariatric Surgery-2 (LABS-2) study. Surg Obes Relat Dis 2013 9 926 935. doi: 10.1016/j.soard.2013.01.023
19. Smith MD, Patterson E, Wahed AS, Thirty-day mortality after bariatric surgery: independently adjudicated causes of death in the longitudinal assessment of bariatric surgery. Obes Surg 2011 21 1687 1692. doi: 10.1007/s11695-011-0497-8
20. Hutter MM, Schirmer BD, Jones DB, Ko CY, Cohen ME, Merkow RP, Nguyen NT, First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg 2011 254 410 420. discussion 420. doi: 10.1097/SLA.0b013e31822c9dac
21. Longitudinal Assessment of Bariatric Surgery (LABS) Consortium Flum DR, Belle SH, King WC, Longitudinal Assessment of Bariatric Surgery (LABS) Consortium Peri-operative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009 361 445. doi: 10.1056/NEJMoa0901836
22. Gosman GG, King WC, Schrope B, Steffen KJ, Strain GW, Courcoulas AP, Flum DR, Pender JR, Simhan HN, Reproductive health of women electing bariatric surgery. Fertil Steril 2010 94 1426 1431. doi: 10.1016/j.fertnstert.2009.08.028
23. Puzziferri N, Roshek TB III, Mayo HG, Gallagher R, Belle SH, Livingston EH, Long-Term follow-up after bariatric surgery: A systematic review. JAMA 2014 312 934 942. doi: 10.1001/jama.2014.10706
24. Gletsu-Miller N, Wright BN, Mineral malnutrition following bariatric surgery. Adv Nutr 2013 4 506 517. doi: 10.3945/an.113.004341
25. Mechanick JI, Youdim A, Jones DB, Garvey WT, Hurley DL, McMahon MM, Heinberg LJ, Kushner R, Adams TD, Shikora S, Dixon JB, Brethauer S, American Association of Clinical Endocrinologists; Obesity Society; American Society for Metabolic & Bariatric Surgery Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient-2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring) 2013 21 SUPPL 1 S1 S27. doi: 10.1002/oby.20461
26. Frenkel RE, Brodsky MC, Spoor TC, Adult-onset cyclic esotropia and optic atrophy. J Clin Neuroophthalmol 1986 6 27 30
27. Ikramuddin S, Blackstone RP, Brancatisano A, Effect of reversible intermittent intra-Abdominal vagal nerve blockade on morbid obesity: the ReCharge randomized clinical trial. JAMA 2014 312 915 922. doi: 10.1001/jama.2014.10540
28. Courcoulas AP, Christian NJ, Belle SH, Longitudinal Assessment of Bariatric Surgery (LABS) Consortium Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity. JAMA 2013 310 2416 2425. doi: 10.1001/jama.2013.280928
29. Sjöström CD, Lissner L, Wedel H, Sjöström L, Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999 7 477 484
30. Mahawar KK, Graham Y, Carr WR, Jennings N, Schroeder N, Balupuri S, Small PK, Revisional Roux-en-Y gastric bypass and sleeve gastrectomy: A systematic review of comparative outcomes with respective primary procedures. Obes Surg 2015 25 1271 1280
31. Coblijn UK, Verveld CJ, van Wagensveld BA, Lagarde SM, Laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy as revisional procedure after adjustable gastric band-A systematic review. Obes Surg 2013 23 1899 1914. doi: 10.1007/s11695-013-1058-0
32. Cheung D, Switzer NJ, Gill RS, Shi X, Karmali S, Revisional bariatric surgery following failed primary laparoscopic sleeve gastrectomy: A systematic review. Obes Surg 2014 24 1757 1763. doi: 10.1007/s11695-014-1332-9
33. Wang MC, Guo XH, Zhang YW, Zhang YL, Zhang HH, Zhang YC, Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with Type 2 diabetes: A meta-Analysis of randomized controlled trials. Am Surg 2015 81 166 171
34. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, Barakat HA, deRamon RA, Israel G, Dolezal JM, Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995 222 339 350. discussion 350
35. Adams TD, Gress RE, Smith SC, Halverson RC, Simper SC, Rosamond WD, Lamonte MJ, Stroup AM, Hunt SC, Long-Term mortality after gastric bypass surgery. N Engl J Med 2007 357 753 761. doi: 10.1056/NEJMoa066603.
36. Carlsson LM, Peltonen M, Ahlin S, Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012 367 695 704. doi: 10.1056/NEJMoa1112082
37. Eckel RH, Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med 2008 358 1941 1950. doi: 10.1056/NEJMcp0801652
38. Després JP, Arsenault BJ, Côté M, Cartier A, Lemieux I, Abdominal obesity: the cholesterol of the 21st century? Can J Cardiol 2008 24 SUPPL D 7D 12D
39. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, Van Pelt RE, Wang H, Eckel RH, The metabolic syndrome. Endocr Rev 2008 29 777 822. doi: 10.1210/er.2008-0024
40. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention; Hational Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009 120 1640 1645. doi: 10.1161/CIRCULATIONAHA.109.192644
41. Bastien M, Poirier P, Lemieux I, Després JP, Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014 56 369 381. doi: 10.1016/j.pcad.2013.10.016
42. Chaston TB, Dixon JB, Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond) 2008 32 619 628. doi: 10.1038/sj.ijo.0803761
43. Weiss R, Appelbaum L, Schweiger C, Matot I, Constantini N, Idan A, Shussman N, Sosna J, Keidar A, Short-Term dynamics and metabolic impact of abdominal fat depots after bariatric surgery. Diabetes Care 2009 32 1910 1915. doi: 10.2337/dc09-0943
44. Galanakis CG, Daskalakis M, Manios A, Xyda A, Karantanas AH, Melissas J, Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery. World J Surg 2015 39 417 423. doi: 10.1007/s00268-014-2826-2
45. Miller GD, Carr JJ, Fernandez AZ, Regional fat changes following weight reduction from laparoscopic Roux-en-Y gastric bypass surgery. Diabetes Obes Metab 2011 13 189 192. doi: 10.1111/j.1463-1326.2010.01338.x.
46. Toro-Ramos T, Goodpaster BH, Janumala I, Lin S, Strain GW, Thornton JC, Gallagher D, Continued loss in visceral and intermuscular adipose tissue in weight stable women following bariatric surgery. Obesity 2015 23 62 69. doi: 10.1002/oby.20932
47. Gletsu-Miller N, Hansen JM, Jones DP, Go YM, Torres WE, Ziegler TR, Lin E, Loss of total and visceral adipose tissue mass predicts decreases in oxidative stress after weight-loss surgery. Obesity 2009 17 439 446. doi: 10.1038/oby.2008.542
48. Masubuchi Y, [Simultaneous micro-determination of steroid hormones by high performance liquid chromatography (HPLC)] Nihon Yakurigaku Zasshi 1991 97 7 10
49. Dillard TH, Purnell JQ, Smith MD, Raum W, Hong D, Laut J, Patterson EJ, Omentectomy added to Roux-en-Y gastric bypass surgery: A randomized, controlled trial. Surg Obes Relat Dis 2013 9 269 275. doi: 10.1016/j.soard.2011.09.027
50. Herrera MF, Pantoja JP, Velázquez-Fernández D, Cabiedes J, Aguilar-Salinas C, García-García E, Rivas A, Villeda C, Hernández-Ramírez DF, Dávila A, Zaraín A, Potential additional effect of omentectomy on metabolic syndrome, acute-phase reactants, and inflammatory mediators in grade III obese patients undergoing laparoscopic Roux-en-Y gastric bypass: A randomized trial. Diabetes Care 2010 33 1413 1418. doi: 10.2337/dc09-1833
51. Feingold KR, Grunfeld C, Obesity and Dyslipidemia 2015 South Dartmouth MDText.com.Inc
52. Carswell KA, Belgaumkar AP, Amiel SA, Patel AG, A systematic review and meta-Analysis of the effect of gastric bypass surgery on plasma lipid levels. Obes Surg 2016 26 843 855. doi: 10.1007/s11695-015-1829-x.
53. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB, Bariatric surgery and cardiovascular outcomes: A systematic review. Heart 2012 98 1763 1777. doi: 10.1136/heartjnl-2012-301778
54. Zlabek JA, Grimm MS, Larson CJ, Mathiason MA, Lambert PJ, Kothari SN, The effect of laparoscopic gastric bypass surgery on dyslipidemia in severely obese patients. Surg Obes Relat Dis 2005 1 537 542. doi: 10.1016/j.soard.2005.09.009
55. Griffo E, Cotugno M, Nosso G, Saldalamacchia G, Mangione A, Angrisani L, Capaldo B, Effects of sleeve gastrectomy and gastric bypass on postprandial lipid profile in obese type 2 diabetic patients: A 2-year follow-up. Obes Surg 2016 26 1247 1253. doi: 10.1007/s11695-015-1891-4
56. Cunha FM, Oliveira J, Preto J, Saavedra A, Costa MM, Magalhães D, Carvalho D, The effect of bariatric surgery type on lipid profile: An age, sex, body mass index and excess weight loss matched study. Obes Surg 2015 26 1041 1047. doi: 10.1007/s11695-015-1825-1
57. Benetti A, Del Puppo M, Crosignani A, Veronelli A, Masci E, Frigè F, Micheletto G, Panizzo V, Pontiroli AE, Cholesterol metabolism after bariatric surgery in grade 3 obesity: differences between malabsorptive and restrictive procedures. Diabetes Care 2013 36 1443 1447. doi: 10.2337/dc12-1737
58. García-Díaz Jde D, Lozano O, Ramos JC, Gaspar MJ, Keller J, Duce AM, Changes in lipid profile after biliopancreatic diversion. Obes Surg 2003 13 756 760. doi: 10.1381/096089203322509345
59. To VT, Hüttl TP, Lang R, Piotrowski K, Parhofer KG, Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Exp Clin Endocrinol Diabetes 2012 120 547 552. doi: 10.1055/s-0032-1323738
60. Williams DB, Hagedorn JC, Lawson EH, Galanko JA, Safadi BY, Curet MJ, Morton JM, Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis 2007 3 8 13. doi: 10.1016/j.soard.2006.10.003.
61. Canning KL, Brown RE, Wharton S, Sharma AM, Kuk JL, Edmonton obesity staging system prevalence and association with weight loss in a publicly funded referral-based obesity clinic. J Obes 2015 2015 619734. doi: 10.1155/2015/619734
62. Scholle RH, Tiecke RW, Benign migratory glossitis. Ill Dent J 1975 44 228 230
63. Thomas KA, How the NICU environment sounds to a preterm infant. MCN Am J Matern Child Nurs 1989 14 249 251
64. Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT, Resolution of systemic hypertension after laparoscopic gastric bypass. J Gastrointest Surg 2009 13 793 797. doi: 10.1007/s11605-008-0759-5
65. Ricci C, Gaeta M, Rausa E, Asti E, Bandera F, Bonavina L, Long-Term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: A meta-Analysis and meta-regression study with 5-year follow-up. Obes Surg 2015 25 397 405. doi: 10.1007/s11695-014-1442-4
66. Adams TD, Davidson LE, Litwin SE, Health benefits of gastric bypass surgery after 6 years. JAMA 2012 308 1122 1131. doi: 10.1001/2012.jama.11164
67. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, Dahlgren S, Larsson B, Narbro K, Sjöström CD, Sullivan M, Wedel H, Swedish Obese Subjects Study Scientific Group Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004 351 2683 2693. doi: 10.1056/NEJMoa035622
68. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, Castagneto M, Bornstein S, Rubino F, Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015 386 964 973. doi: 10.1016/S0140-6736(15)00075-6
69. Schauer PR, Bhatt DL, Kirwan JP, Wolski K, Brethauer SA, Navaneethan SD, Aminian A, Pothier CE, Kim ES, Nissen SE, Kashyap SR, STAMPEDE Investigators Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014 370 2002 2013. doi: 10.1056/NEJMoa1401329
70. Schauer PR, Mingrone G, Ikramuddin S, Wolfe BM, Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care 2016 39 1 10
71. Merlotti C, Morabito A, Ceriani V, Pontiroli AE, Prevention of type 2 diabetes in obese at-risk subjects: A systematic review and meta-Analysis. Acta Diabetol 2014 51 853 863. doi: 10.1007/s00592-014-0624-9
72. Merlotti C, Morabito A, Pontiroli AE, Prevention of type 2 diabetes; a systematic review and meta-Analysis of different intervention strategies. Diabetes Obes Metab 2014 16 719 727. doi: 10.1111/dom.12270
73. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, Sterling RK, Shiffman ML, Stravitz RT, Sanyal AJ, Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology 2003 37 1286 1292. doi: 10.1053/jhep.2003.50229
74. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH, Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004 40 1387 1395. doi: 10.1002/hep.20466
75. Shalhub S, Parsee A, Gallagher SF, Haines KL, Willkomm C, Brantley SG, Pinkas H, Saff-Koche L, Murr MM, The importance of routine liver biopsy in diagnosing nonalcoholic steatohepatitis in bariatric patients. Obes Surg 2004 14 54 59. doi: 10.1381/096089204772787293
76. Goossens N, Hoshida Y, Song WM, Jung M, Morel P, Nakagawa S, Negro F, Nonalcoholic steatohepatitis is associated with increased mortality in obese patients undergoing bariatric surgery [published online ahead of print October 20, 2015] Clin Gastroenterol Hepatol. doi: 10.1016/j.cgh.2015.10.010. http://www.cghjournal.org/article/S1542-3565(15)01406-8/abstract
77. Demir M, Lang S, Steffen HM, Nonalcoholic fatty liver disease-current status and future directions. J Dig Dis 2015 16 541 557. doi: 10.1111/1751-2980.12291
78. Burza MA, Romeo S, Kotronen A, Svensson PA, Sjöholm K, Torgerson JS, Lindroos AK, Sjöström L, Carlsson LM, Peltonen M, Long-Term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study. PLoS One 2013 8 e60495. doi: 10.1371/journal.pone.0060495
79. Aguilar-Olivos NE, Almeda-Valdes P, Aguilar-Salinas CA, Uribe M, Méndez-Sánchez N, The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome. Metabolism 2015. doi: 10.1016/j.metabol.2015.09.004
80. Mathurin P, Hollebecque A, Arnalsteen L, Buob D, Leteurtre E, Caiazzo R, Pigeyre M, Verkindt H, Dharancy S, Louvet A, Romon M, Pattou F, Prospective study of the long-Term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009 137 532 540. doi: 10.1053/j.gastro.2009.04.052
81. Caiazzo R, Lassailly G, Leteurtre E, Baud G, Verkindt H, Raverdy V, Buob D, Pigeyre M, Mathurin P, Pattou F, Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: A 5-year controlled longitudinal study. Ann Surg 2014 260 893 898. discussion 898. doi: 10.1097/SLA.0000000000000945
82. Selvin E, Paynter NP, Erlinger TP, The effect of weight loss on C-reactive protein: A systematic review. Arch Intern Med 2007 167 31 39. doi: 10.1001/archinte.167.1.31
83. Heilbronn LK, Noakes M, Clifton PM, Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women. Arterioscler Thromb Vasc Biol 2001 21 968 970
84. Silva FM, de Almeida JC, Feoli AM, Effect of diet on adiponectin levels in blood. Nutr Rev 2011 69 599 612. doi: 10.1111/j.1753-4887.2011.00414.x.
85. Esposito K, Pontillo A, Di Palo C, Giugliano G, Masella M, Marfella R, Giugliano D, Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: A randomized trial. JAMA 2003 289 1799 1804. doi: 10.1001/jama.289.14.1799
86. Saleh MH, Bertolami MC, Assef JE, Taha MI, de Freitas W Jr, Petisco AC, Barretto RB, Le Bihan DC, Barbosa JE, de Jesus CA, Sousa AG, Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery. Obes Surg 2012 22 1701 1707. doi: 10.1007/s11695-012-0706-0
87. Gebhart A, Young M, Villamere J, Shih A, Nguyen NT, Changes in high-sensitivity C-reactive protein levels after laparoscopic gastric stapling procedures versus laparoscopic gastric banding. Am Surg 2014 80 1044 1048
88. Csendes A, Maluenda F, Burgos AM, A prospective randomized study comparing patients with morbid obesity submitted to laparotomic gastric bypass with or without omentectomy. Obes Surg 2009 19 490 494. doi: 10.1007/s11695-008-9660-2
89. Illán-Gómez F, Gonzálvez-Ortega M, Orea-Soler I, Alcaraz-Tafalla MS, Aragón-Alonso A, Pascual-Díaz M, Lozano-Almela ML, Obesity and inflammation: change in adiponectin, C-reactive protein, tumour necrosis factor-Alpha and interleukin-6 after bariatric surgery. Obes Surg 2012 22 950 955. doi: 10.1007/s11695-012-0643-y.
90. Laimer M, Ebenbichler CF, Kaser S, Sandhofer A, Weiss H, Nehoda H, Aigner F, Patsch JR, Markers of chronic inflammation and obesity: A prospective study on the reversibility of this association in middle-Aged women undergoing weight loss by surgical intervention. Int J Obes Relat Metab Disord 2002 26 659 662. doi: 10.1038/sj.ijo.0801970
91. Monzillo LU, Hamdy O, Horton ES, Ledbury S, Mullooly C, Jarema C, Porter S, Ovalle K, Moussa A, Mantzoros CS, Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 2003 11 1048 1054. doi: 10.1038/oby.2003.144
92. Vázquez LA, Pazos F, Berrazueta JR, Fernández-Escalante C, García-Unzueta MT, Freijanes J, Amado JA, Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005 90 316 322. doi: 10.1210/jc.2003-032059
93. Agrawal V, Krause KR, Chengelis DL, Zalesin KC, Rocher LL, McCullough PA, Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein. Surg Obes Relat Dis 2009 5 20 26. doi: 10.1016/j.soard.2008.07.011
94. Kopp HP, Krzyzanowska K, Möhlig M, Spranger J, Pfeiffer AF, Schernthaner G, Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 2005 29 766 771. doi: 10.1038/sj.ijo.0802983
95. Hirsch FF, Pareja JC, Geloneze SR, Chaim E, Cazzo E, Geloneze B, Comparison of metabolic effects of surgical-induced massive weight loss in patients with long-Term remission versus non-remission of type 2 diabetes. Obes Surg 2012 22 910 917. doi: 10.1007/s11695-012-0589-0
96. Julve J, Pardina E, Pérez-Cuéllar M, Ferrer R, Rossell J, Baena-Fustegueras JA, Fort JM, Lecube A, Blanco-Vaca F, Sánchez-Quesada JL, Peinado-Onsurbe J, Bariatric surgery in morbidly obese patients improves the atherogenic qualitative properties of the plasma lipoproteins. Atherosclerosis 2014 234 200 205. doi: 10.1016/j.atherosclerosis.2014.02.034
97. Toda N, Okamura T, Obesity impairs vasodilatation and blood flow increase mediated by endothelial nitric oxide: An overview. J Clin Pharmacol 2013 53 1228 1239. doi: 10.1002/jcph.179
98. Mauricio MD, Aldasoro M, Ortega J, Vila JM, Endothelial dysfunction in morbid obesity. Curr Pharm Des 2013 19 5718 5729
99. Timmerman KL, Volpi E, Endothelial function and the regulation of muscle protein anabolism in older adults. Nutr Metab Cardiovasc Dis 2013 23 SUPPL 1 S44 S50. doi: 10.1016/j.numecd.2012.03.013
100. Brethauer SA, Heneghan HM, Eldar S, Gatmaitan P, Huang H, Kashyap S, Gornik HL, Kirwan JP, Schauer PR, Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients. Surg Endosc 2011 25 2650 2659. doi: 10.1007/s00464-011-1620-6
101. Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A, Shah AM, Kearney MT, Endothelial function and weight loss in obese humans. Obes Surg 2005 15 1055 1060. doi: 10.1381/0960892054621134
102. Lupoli R, Di Minno MN, Guidone C, Cefalo C, Capaldo B, Riccardi G, Mingrone G, Effects of bariatric surgery on markers of subclinical atherosclerosis and endothelial function: A meta-Analysis of literature studies. Int J Obes (Lond) 2016 40 395 402. doi: 10.1038/ijo.2015.187
103. Sarkhosh K, Switzer NJ, El-Hadi M, Birch DW, Shi X, Karmali S, The impact of bariatric surgery on obstructive sleep apnea: A systematic review. Obes Surg 2013 23 414 423. doi: 10.1007/s11695-012-0862-2
104. Romero-Corral A, Caples SM, Lopez-Jimenez F, Somers VK, Interactions between obesity and obstructive sleep apnea: implications for treatment. Chest 2010 137 711 719. doi: 10.1378/chest.09-0360
105. Ashrafian H, Toma T, Rowland SP, Harling L, Tan A, Efthimiou E, Darzi A, Athanasiou T, Bariatric surgery or non-surgical weight loss for obstructive sleep apnoea? A systematic review and comparison of meta-Analyses. Obes Surg 2015 25 1239 1250. doi: 10.1007/s11695-014-1533-2
106. Jordan AS, McSharry DG, Malhotra A, Adult obstructive sleep apnoea. Lancet 2014 383 736 747. doi: 10.1016/S0140-6736(13)60734-5
107. Grams J, Garvey WT, Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action. Curr Obes Rep 2015 4 287 302. doi: 10.1007/s13679-015-0155-x.
108. Meek CL, Lewis HB, Reimann F, Gribble FM, Park AJ, The effect of bariatric surgery on gastrointestinal and pancreatic peptide hormones. Peptides 2016 77 28 37. doi: 10.1016/j.peptides.2015.08.013
109. Browning MG, Franco RL, Cyrus JC, Celi F, Evans RK, Changes in resting energy expenditure in relation to body weight and composition following gastric restriction: A systematic review. Obes Surg 2016 1 9
110. Cole AJ, Teigen LM, Jahansouz C, Earthman CP, Sibley SD, The influence of bariatric surgery on serum bile acids in humans and potential metabolic and hormonal implications: A systematic review. Curr Obes Rep 2015 4 441 450. doi: 10.1007/s13679-015-0171-x.
111. Miyazaki-Anzai S, Masuda M, Levi M, Keenan AL, Miyazaki M, Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis. PLoS One 2014 9 e108270. doi: 10.1371/journal.pone.0108270
112. Penney NC, Kinross J, Newton RC, Purkayastha S, The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: A systematic review. Int J Obes (Lond) 2015 39 1565 1574. doi: 10.1038/ijo.2015.115
113. Tremaroli V, Karlsson F, Werling M, Ståhlman M, Kovatcheva-Datchary P, Olbers T, Fändriks L, le Roux CW, Nielsen J, Bäckhed F, Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-Term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab 2015 22 228 238. doi: 10.1016/j.cmet.2015.07.009
114. Look AHEAD Research Group Wing RR, Bolin P, Brancati FL, Look AHEAD Research Group Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013 369 145. doi: 10.1056/NEJMoa1212914
115. Sjöström L, Peltonen M, Jacobson P, Bariatric surgery and long-Term cardiovascular events. JAMA 2012 307 56 65. doi: 10.1001/jama.2011.1914
116. Sjöström L, Narbro K, Sjöström CD, Swedish Obese Subjects Study Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007 357 741 752. doi: 10.1056/NEJMoa066254
117. Kwok CS, Pradhan A, Khan MA, Anderson SG, Keavney BD, Myint PK, Mamas MA, Loke YK, Bariatric surgery and its impact on cardiovascular disease and mortality: A systematic review and meta-Analysis. Int J Cardiol 2014 173 20 28. doi: 10.1016/j.ijcard.2014.02.026
118. Sjöström L, Gummesson A, Sjöström CD, Swedish Obese Subjects Study Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial. Lancet Oncol 2009 10 653 662. doi: 10.1016/S1470-2045(09)70159-7
119. Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC, Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring) 2009 17 796 802. doi: 10.1038/oby.2008.610
120. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA, The effectiveness and risks of bariatric surgery: An updated systematic review and meta-Analysis, 2003-2012. J Amer Med Assoc Surg 2014 149 275 287. doi: 10.1001/jamasurg.2013.3654